Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries

被引：33

作者：

Giné, E ^{[1
]}

Rovira, M ^{[1
]}

Real, I ^{[1
]}

Burrel, M ^{[1
]}

Montaña, J ^{[1
]}

Carreras, E ^{[1
]}

Montserrat, E ^{[1
]}

机构：

[1] Univ Barcelona, Hosp Clin, IDIBAPS, Unit Intervent Vasc Radiol, Barcelona, Spain

来源：

BONE MARROW TRANSPLANTATION | 2003年 / 31卷 / 10期

关键词：

hemorrhagic cystitis; hemopoietic cell transplantation; selective embolization;

D O I：

10.1038/sj.bmt.1703954

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Hemorrhagic cystitis (HC) is a common and sometimes life-threatening complication of hemopoietic cell transplantation (HCT) occurring in 7-52% of transplant recipients. In this setting it is usually either related to the use of cyclophosphamide or to a viral infection (BK, JC viruses and adenovirus type 11). Treatment is based on hyperhydration, platelet and blood-cell transfusions, bladder irrigation and pain management. Where these measures have failed to control HC, numerous therapeutic approaches including surgery have been tried with poor success. We report two HC patients with severe HC successfully treated with selective embolization of the vesical arteries.

引用

页码：923 / 925

页数：3

共 13 条

[1]

BARONCIANI D, 1995, BONE MARROW TRANSPL, V16, P267

[2] High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine [J].

Childs, R ;

Sanchez, C ;

Engler, H ;

Preuss, J ;

Rosenfeld, S ;

Dunbar, C ;

van Rhee, F ;

Plante, M ;

Phang, S ;

Barrett, AJ .

BONE MARROW TRANSPLANTATION, 1998, 22 (09) :889-893

[3] EFFICACY OF MESNA FOR PREVENTION OF HEMORRHAGIC CYSTITIS AFTER HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY [J].

HASELBERGER, MB ;

SCHWINGHAMMER, TL .

ANNALS OF PHARMACOTHERAPY, 1995, 29 (09) :918-921

[4] Successful hyperbaric oxygen treatment of life-threatening hemorrhagic cystitis after allogeneic bone marrow transplantation [J].

Hattori, K ;

Yabe, M ;

Matsumoto, M ;

Kudo, Y ;

Yasuda, Y ;

Inoue, H ;

Minami, S ;

Miyakita, H ;

Kawamura, N ;

Komori, K ;

Yamamoto, I ;

Yabe, H .

BONE MARROW TRANSPLANTATION, 2001, 27 (12) :1315-1317

[5]

Hayes MC, 1996, BRIT J UROL, V78, P311

[6] Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir [J].

Held, TK ;

Biel, SS ;

Nitsche, A ;

Kurth, A ;

Chen, S ;

Gelderblom, HR ;

Siegert, W .

BONE MARROW TRANSPLANTATION, 2000, 26 (03) :347-350

[7] Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation [J].

Kawakami, M ;

Ueda, S ;

Maeda, T ;

Karasuno, T ;

Teshima, H ;

Hiraoka, A ;

Nakamura, H ;

Tanaka, K ;

Masaoka, T .

BONE MARROW TRANSPLANTATION, 1997, 20 (06) :485-490

[8] Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation [J].

Koc, S ;

Hagglund, H ;

Ireton, RC ;

Perez-Simon, JA ;

Collins, SJ ;

Appelbaum, FR .

BONE MARROW TRANSPLANTATION, 2000, 26 (08) :899-901

[9] Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature [J].

Ordemann, R ;

Naumann, R ;

Geissler, G ;

Bornhauser, M ;

Schuler, U ;

Ehninger, G .

BONE MARROW TRANSPLANTATION, 2000, 25 (09) :981-985

[10]

PUCHOL MDF, 1998, ACTAS UROL ESP, V22, P519

← 1 2 →